XML 38 R22.htm IDEA: XBRL DOCUMENT v3.25.2
LICENSE REVENUES (Tables)
 6 Months Ended
Jun. 30, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Abstract]  
Schedule of License and Grant Revenue
The following table summarizes the total revenue recorded in the Company’s condensed consolidated statements of operations (in thousands):
THREE MONTHS ENDED
JUNE 30,		SIX MONTHS ENDED
JUNE 30,
2025202420252024
License fee revenue
Scithera, Inc.$1,300 $— $1,300 $— 
Regeneron Pharmaceuticals, Inc.— 100 — 100 
Total license fee revenue$1,300 $100 $1,300 $100